Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.
about
Immunologic aspect of ovarian cancer and p53 as tumor antigen.Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-AnalysisClinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancerP53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis.Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma.p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.Autoantibodies to tumor-associated antigens in breast carcinoma.Prognostic and diagnostic value of spontaneous tumor-related antibodiesAnti-tumor antibodies in ovarian cancer.Ascitic complement system in ovarian cancerUsage of cancer associated autoantibodies in the detection of diseasep53 autoantibodies, cytokine levels and ovarian carcinogenesisAutoantibodies as biomarkers for ovarian cancer.Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.A systematic review of humoral immune responses against tumor antigens.Autoantibodies in cancer: prognostic biomarkers and immune activation.Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers.Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.Diagnostic and prognostic significance of circulating tumor suppressor gene p53 autoantibodies in patients with gestational trophoblastic tumors.
P2860
Q24814703-66227A4A-89ED-4F50-9173-1A089CD9C154Q26785421-F79CD8C8-D7B6-4EC2-9D19-9FB9CA4C8FF2Q27002356-0DCD2B01-9E5D-4295-B160-9558A550AFAFQ30740899-214A1D93-3805-4CD2-8D01-3237D18B46B1Q33608271-E7B5F0B9-928A-4E46-B8AF-66B0EA421B82Q33633387-A2183088-2561-4D81-B9B9-6B699DB34B38Q33725961-26C78C54-2923-4529-98E2-040C56FE8E54Q34219323-7B604A7E-DBEB-4551-B9A9-F57ED4BC01A8Q34339160-DC606A28-64E5-4D6E-91F2-E47230BB3C12Q34475795-408F4A5A-D5FE-4341-B611-62189D905E55Q36232263-63CF78D2-0114-407F-A2CD-0145EF37AC7FQ36616364-7EE36684-E2B6-4B56-B91B-DCA6460020D2Q37217734-FCDDF70D-54FE-4E83-84B3-58C644F0536DQ37223836-4302F7FE-1A3A-441D-93E5-9ECC1D8A369EQ37224335-FDABCB1E-7D36-4783-B3B5-82DC227316E3Q37322280-E0A2A80D-257A-47E8-B8C4-9E06E78BE0E6Q37435862-F6173F21-78D6-40B9-98FB-732A09D6B786Q37945787-3A76C151-6404-477D-863F-7490B16D2D3FQ38060678-1C4047D3-2940-43F5-A0AB-16BF0808F74DQ38913999-6AF5793B-408B-41A6-9FC0-5D798095A8A9Q47793370-B064BC97-E8B6-49B5-9F8E-B83EA5B81142Q47806935-B75D1E69-E9F4-41C5-9A36-2A9AEAD488EC
P2860
Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Clinical significance of serum ...... epithelial ovarian carcinoma.
@en
type
label
Clinical significance of serum ...... epithelial ovarian carcinoma.
@en
prefLabel
Clinical significance of serum ...... epithelial ovarian carcinoma.
@en
P2093
P2860
P1433
P1476
Clinical significance of serum ...... n epithelial ovarian carcinoma
@en
P2093
A G Zeimet
B Abendstein
E Müller-Holzner
G Daxenbichler
P2860
P304
P356
10.1002/(SICI)1097-0142(20000315)88:6<1432::AID-CNCR22>3.0.CO;2-8
P407
P577
2000-03-01T00:00:00Z